We received funding from the UCLA School of Medicine and the Jonsson Comprehensive Cancer Center for Tackling Glioblastoma Using Radioligand Therapy: The UCLA Neurotheranostics Program.

The Neurotheranostics program that will bring together the knowledge of GBM biology, radioligand therapy (RLT), and design of brain-penetrant ligands and pharmacology to effectively design targeted-RLT probes for the specific treatment of GBM. The program is focused on the identification of druggable targets at the surface of GBM tumors and the development of brain-penetrant molecules for PET imaging and RLT. 

Principal Investigators: Drs. Christine E. Mona, David A. Nathanson, and Elie Besserer-Offroy.
Co-Investigators: Drs. Guiseppe Carlucci, Timothy F. Cloughesy, and Johannes Czernin.